Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas ; volume:7 ; number:1 ; day:5 ; month:12 ; year:2019 ; pages:1-12 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (5.12.2019), 1-12, 12.2019
- Creator
-
Al-Ali, Ruslan
Bauer, Katharina
Park, Jong-Whi
Abdulla, Ruba Al
Fermi, Valentina
Deimling, Andreas von
Herold-Mende, Christel
Mallm, Jan-Philipp
Herrmann, Carl
Wick, Wolfgang
Turcan, S̨evin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-019-0851-y
- URN
-
urn:nbn:de:101:1-2020040123564959986339
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Al-Ali, Ruslan
- Bauer, Katharina
- Park, Jong-Whi
- Abdulla, Ruba Al
- Fermi, Valentina
- Deimling, Andreas von
- Herold-Mende, Christel
- Mallm, Jan-Philipp
- Herrmann, Carl
- Wick, Wolfgang
- Turcan, S̨evin
- SpringerLink (Online service)
Other Objects (12)
![Gliomas : [indexed in PubMed-Medline]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Gliomas : [indexed in PubMed-Medline]
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
How to use and assess qualitative research methods
Concurrent gliomas in patients with multiple sclerosis
In vitro and in vivo modeling of gliomagenesis based on the IDH1R132H mutation
Gliomas : [indexed in PubMed-Medline]
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
How to use and assess qualitative research methods
Concurrent gliomas in patients with multiple sclerosis
In vitro and in vivo modeling of gliomagenesis based on the IDH1R132H mutation
Gliomas : [indexed in PubMed-Medline]
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
How to use and assess qualitative research methods
Concurrent gliomas in patients with multiple sclerosis